Pamidronate for Bone Metastases in Thyroid Cancer
Author Information
Author(s): Vitale G, Fonderico F, Martignetti A, Caraglia M, Ciccarelli A, Nuzzo V, Abbruzzese A, Lupoli G
Primary Institution: Università degli Studi “Federico II”
Hypothesis
Can pamidronate improve the quality of life and reduce bone pain in patients with thyroid cancer and bone metastases?
Conclusion
Pamidronate treatment significantly relieves bone pain and improves the quality of life for thyroid cancer patients with bone metastases.
Supporting Evidence
- Pamidronate significantly decreased bone pain in patients.
- Performance status improved nearly significantly.
- Quality of life showed remarkable improvement.
- Partial radiographic response of bone lesions was observed in 2 out of 10 patients.
Takeaway
This study found that a medicine called pamidronate can help people with thyroid cancer feel less pain in their bones and feel better overall.
Methodology
10 thyroid cancer patients received monthly pamidronate infusions for 12 cycles, and their pain and quality of life were evaluated.
Limitations
No significant decrease in analgesic consumption was recorded.
Participant Demographics
10 patients with thyroid cancer and painful osteolytic bone metastases.
Statistical Information
P-Value
0.0052
Statistical Significance
p=0.0052
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website